Model
Edge
Cero Therapeutics Holdings, Inc.
PBAX
Filing Type
8-K
Filing Date
10/13/2025
Updated
10/14/25, 7:11 AM
Filing
8-K
Earnings Release
Exhibits
8-K
Material Contracts, Unregistered Sales of Equity Securities
EX-3.1
FORM OF CERTIFICATE OF DESIGNATION OF PREFERENCES, RIGHTS AND LIMITATIONS OF THE SERIES E CONVERTIBLE PREFERRED STOCK
EX-10.1
SECURITIES PURCHASE AGREEMENT, DATED AS OF OCTOBER 14, 2025, BY AND BETWEEN CERO THERAPEUTICS HOLDINGS, INC. AND THE INVESTORS SIGNATORY THERETO
EX-10.2
FORM OF REGISTRATION RIGHTS AGREEMENT BY AND BETWEEN CERO THERAPEUTICS HOLDINGS, INC. AND THE INVESTORS SIGNATORY THERETO